Lepu Medical Technology (Beijing)

Founder and Chairman Pu Zhongjie retains ultimate influence as controlling shareholder, though his son Pu Fei, who serves as CEO, is increasingly involved in strategic direction. Investment decisions flow through the corporate structure rather than a separate investment committee, consistent with Lepu's identity as an operating company that invests off its own balance sheet.

Lepu invests as a publicly traded corporation, not a family office. Its capital comes from retained earnings and the public equity market rather than segregated family wealth, and its deals must serve industrial logic — strengthening the core cardiovascular platform — rather than maximizing financial returns independently. This makes it a strategic corporate investor, not a diversified allocator.

PW Medtech is an affiliate connected through founder Pu Zhongjie and his wife Zhang Yue'e, but it operates as a separate entity from the listed Lepu Medical parent. The precise ownership and governance separation between the two is not publicly detailed, reflecting the opaque holding structures common among Chinese family-linked industrial groups.

Lepu's corporate development strategy favors control positions and majority stakes, especially in assets that can be integrated into its device and pharmaceutical supply chains. However, the subsidiary listing of Lepu Biopharma in 2023 demonstrated a parallel willingness to use partial sell-downs as a financing and value-realization tool.

Lepu's mandate is tightly focused on cardiovascular health and adjacent medical technologies. The firm does not invest in consumer goods, general technology, real estate, or sectors outside the healthcare ecosystem, nor does it operate as a passive financial investor — its capital is deployed where it can exert operational influence.

Warburg Pincus was an early institutional backer between 2007 and 2013, assisting Lepu with balance-sheet restructuring and corporate governance upgrades ahead of the Shenzhen Stock Exchange listing in 2009. Its exit marked Lepu's transition from private growth-stage company to public-market entity, with capital deployment shifting to cash-flow and public-equity financing.

Yes. Pu Fei, son of founder Pu Zhongjie, holds the CEO position, indicating a succession path is active. Pu Zhongjie remains Chairman and controlling shareholder, and his wife Zhang Yue'e's involvement in affiliated structures suggests the family intends to maintain multi-generational influence across the Lepu ecosystem.